SCHEMBL20114701

SCHEMBL20114701

Cc1ccc(-c2ccc3c(c2)c2cc(-c4ccc(C)cc4C)ccc2n3-c2ccc(C#N)c(-c3nc(-c4ccccc4)nc(-c4ccccc4)n3)c2)c(C)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 2/20 0.39
ALDH1A1 P00352 1/20 0.39
LMNA P02545 1/20 0.39
MAPK1 P28482 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
NR3C1 P04150 2/20 0.37
ABCG2 Q9UNQ0 3/20 0.36
AR P10275 1/20 0.33
GRM2 Q14416 1/20 0.33
KDM4E B2RXH2 2/20 0.32
GABRA1 P14867 1/20 0.32
GABRG2 P18507 1/20 0.32
GABRB3 P28472 1/20 0.32
GABRA5 P31644 1/20 0.32
GABRA3 P34903 1/20 0.32
GABRA2 P47869 1/20 0.32
PGR P06401 1/20 0.32
MAPT P10636 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
ADORA3 P0DMS8 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20156284 0.97 ALDH1A1 (0.37) HPGDALDH1A1LMNAMAPK1SMN1; SMN2
SCHEMBL20114708 0.93 HPGD (0.40) HPGDALDH1A1LMNAMAPK1SMN1; SMN2
SCHEMBL22243211 0.92 ALDH1A1 (0.36) HPGDALDH1A1LMNAMAPK1SMN1; SMN2
SCHEMBL20114717 0.91 AR (0.42) HPGDALDH1A1LMNAMAPK1SMN1; SMN2
SCHEMBL20115013 0.91 ALDH1A1 (0.44) HPGDALDH1A1LMNAMAPK1SMN1; SMN2
SCHEMBL20150441 0.90 ALDH1A1 (0.38) HPGDALDH1A1LMNAMAPK1SMN1; SMN2
SCHEMBL20793940 0.89 ALDH1A1 (0.34) HPGDALDH1A1LMNAMAPK1SMN1; SMN2
SCHEMBL27021819 0.89 ALDH1A1 (0.38) HPGDALDH1A1LMNAMAPK1SMN1; SMN2
SCHEMBL20150437 0.89 MAPK1 (0.41) HPGDALDH1A1LMNAMAPK1SMN1; SMN2
SCHEMBL20114705 0.88 AR (0.40) HPGDALDH1A1LMNAMAPK1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10421746-B2 Organic molecules, especially for use in organic optoelectronic devices CYNORA GMBH (DE) 2019-09-24 US disclosed
EP-3315581-B1 ORGANIC MOLECULES, IN PARTICULAR FOR USE IN ORGANIC OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2019-01-02 EP disclosed
US-20180134686-A1 ORGANIC MOLECULES, ESPECIALLY FOR USE IN ORGANIC OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2018-05-17 US disclosed
EP-3315581-A1 ORGANIC MOLECULES, IN PARTICULAR FOR USE IN ORGANIC OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2018-05-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180134686-A1 ORGANIC MOLECULES, ESPECIALLY FOR USE IN ORGANIC OPTOELECTRONIC DEVICES OR10J3, EPCAM, F12 HPGD 2446/4885ALDH1A1 387/4885LMNA 3586/4885
US-10421746-B2 Organic molecules, especially for use in organic optoelectronic devices OR10J3, EPCAM, F12 HPGD 2446/4885ALDH1A1 387/4885LMNA 3586/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.